Growth hormone‐releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer
Laura Muñoz‐Moreno(Universidad de Alcalá), Ana M. Bajo(Universidad de Alcalá), Marı́a J. Carmena(Universidad de Alcalá), Andrew V. Schally(University of Miami), Juan Carlos Prieto(Universidad de Santiago de Chile)
Cited by 22
Related Papers
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755
Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain
|Pain|2006|187
A deep neural network to assess spontaneous pain from mouse facial expressions
|Molecular Pain|2018|174
Interaction of vasoactive intestinal peptide with human blood mononuclear cells
|Molecular and Cellular Endocrinology|1981|149
Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5
|Proceedings of the National Academy of Sciences|1997|138